Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. - Wikidata - wikimedia - TriplyDB

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

http://www.wikidata.org/entity/Q30393860

about

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.Checkpoint inhibition in meningiomas.Assessment of Brain Tumor Response: RANO and Its Offspring.Microsurgical management of primary jugular foramen meningiomas: a series of 22 cases and review of the literature.SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake Response Assessment in Neuro-Oncology Clinical Trials.Computer-based radiological longitudinal evaluation of meningiomas following stereotactic radiosurgery.Recurred Intracranial Meningioma: A Retrospective Analysis for Treatment Outcome and Prognostic Factor.Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.Diffusivity changes in bevacizumab-responding and -refractory meningioma.Systemic therapy for recurrent meningioma.Recent Advances in Intradural Spinal Tumors.Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).Recent advances in managing/understanding meningioma.Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.An overview of meningiomas Antiangiogenic Treatment of Meningiomas

P2860

Q26741529-E3125AD7-816B-4844-A44F-F299AE9D9666 Q35106253-C366F959-D564-4436-AA17-AD4F81BC03F0 Q36618245-E537B889-EDA8-4CB1-B48A-6F490F68F5EB Q36785144-8354142D-7D6C-4185-8C5B-45CF01D9F5C3 Q38430591-FDA06181-D4DB-4005-BA86-C649749356BC Q38711744-B76257DD-ABA6-4893-BE4D-F3DB8D5FD44B Q38838646-7E204D98-F2CF-4B07-902A-79B92F63CE94 Q38855020-CAF08184-11CA-448A-8723-DD83BBC355DE Q38873834-92E9640F-0BA3-4F95-99DB-3D8C337A75CD Q39023691-1C9CF3E8-8BEC-41AC-9431-DE363CFDCA2A Q40582859-1418C6BF-0600-48C5-A08F-11747BF073FC Q42396777-4E4F0228-CC72-432A-AE08-06A6CAACFBAA Q42702315-9EC83FD7-CBB7-42C5-AD57-65C171EFBF02 Q45945655-362C8134-DF18-42F3-AA18-4ACD15ABACBC Q46736447-A8216493-601D-4C7C-B17B-551072167687 Q47105158-0A520BCE-7BF2-4300-B02F-527582542A36 Q47122159-1F48112A-F437-4F58-9BA8-8EC01F621872 Q48111906-814760E3-58F0-4228-8283-9BF98C7A4D36 Q48787594-6D85503D-B5C2-4DAD-A7BC-72B3079BFE6E Q50027408-E9473F97-973D-4377-9128-1D5DEB55D3CB Q50664835-2BB63FC3-FF7F-401B-8B79-6707706CB940 Q53246945-F2339459-D41A-4D6F-88C3-698D006CE367 Q54109244-4D8B5FDC-D35E-45ED-9A5F-31F2479000C6 Q55313347-2822EF0F-7340-4437-97E0-77C930B863B1 Q57163869-53F339C7-AC80-47BA-BC4D-D5110C441B8C Q58002991-0DFB0B63-C103-40F5-8341-501D038A1089

P2860

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

http://www.wikidata.org/entity/Q30393860

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@ast

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en-gb

type

label

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@ast

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en-gb

prefLabel

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@ast

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en-gb

P1433

Q30393860-AB8ED10B-FD32-4838-912D-4782B9517604

P1476

Q30393860-5E282EF8-9AA4-4836-A015-C6843725A9F8

P2093

Q30393860-0CF5E11A-EFAE-4AF0-802E-8A3D94D37407

Q30393860-175B8AED-D46B-4585-B238-DE15DB85F458

Q30393860-1EF24140-90F8-402D-B2CA-887CBD036B9D

Q30393860-418E5F19-CAB8-4EFF-A9EB-E30FF6C8C39E

Q30393860-4C0908C1-87D1-4520-9908-109614B59A53

Q30393860-82D55FBC-57B1-4F65-9901-3F48F1A56680

Q30393860-A44D8BC7-AAAC-436D-B0D5-BE739545E852

Q30393860-C3184EA1-6B2D-4AF1-ABAA-02EE37A81C74

Q30393860-FA2755FA-67C1-4638-A14A-A58A58260F6D

P2860

Q30393860-067284DF-05D3-4EFB-9695-44A8735786AA

Q30393860-1E19157F-751B-4589-88E6-BD72FE027EB2

Q30393860-2D110864-59E4-405A-880E-CD0E68EBC9E0

Q30393860-39E69AA8-391D-4031-B0AB-71C9400C00E5

Q30393860-3D305523-46BD-4B31-92D6-B96B8B84571D

Q30393860-55BF074E-D8F8-4D1E-A7BA-59042DA0949F

Q30393860-5E3BE8B8-FF50-47B1-A297-553207A94B9D

Q30393860-60850D04-CB93-45B6-9074-1F729A50CA3E

Q30393860-6604737A-27C8-4A17-B9CC-696767EF0129

Q30393860-6CE18891-ED1B-4235-94BD-62EBD3301FC6

P304

Q30393860-A6980B08-B8FA-48CA-A8F3-3384914B80B3

P31

Q30393860-A2DAEEA1-1E6D-48D5-A752-D72998FC7822

P356

Q30393860-43FE121B-E209-4BE0-BB04-DF7E2483EEF6

P433

Q30393860-66BFAA8A-6FE7-4ABA-B70F-00649BE0744B

P478

Q30393860-E48FC9EC-E6B3-42F8-A376-07D4C317FD62

P50

Q30393860-692D789B-65D2-4E3E-A59A-D3C2E426D276

Q30393860-7991DC34-000E-4A26-B180-C9E14C095BA4

P577

Q30393860-6EF67DB8-CE9D-4302-9EA9-98B9D39C434D

P5875

Q30393860-16F6B43D-80E4-40D2-8ABE-58B38755CC67

P698

Q30393860-0F4B9329-0818-46B6-8725-30F41C1FD1EB

P921

Q30393860-AE4A32F2-2F51-4570-AA6B-62F65BD02DC5

P932

Q30393860-DCB60649-2AD6-45E9-A3B6-DF4D31F37C59

P356

P1433

P1476

Historical benchmarks for medi ...... ory meningioma: a RANO review.

@en

P2093

Damien Weber

http://www.w3.org/2001/XMLSchema#string

David Schiff

http://www.w3.org/2001/XMLSchema#string

Igor Barani

http://www.w3.org/2001/XMLSchema#string

Jeffrey Raizer

http://www.w3.org/2001/XMLSchema#string

Katherine Panageas

http://www.w3.org/2001/XMLSchema#string

Leland Rogers

http://www.w3.org/2001/XMLSchema#string

Marc Chamberlain

http://www.w3.org/2001/XMLSchema#string

Michael Vogelbaum

http://www.w3.org/2001/XMLSchema#string

Patrick Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Temozolomide for treatment-resistant recurrent meningioma.

Salvage chemotherapy with CPT-11 for recurrent meningioma.

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma

Hydroxyurea treatment of meningiomas: a pilot study.

Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.

The role of progesterone receptors in meningioma.

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

P304

829-840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOT330

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Michael McDermott

P577

2014-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260117047

http://www.w3.org/2001/XMLSchema#string

P698

24500419

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4022224

http://www.w3.org/2001/XMLSchema#string